News

Ardelyx, Inc. announced a license agreement with Knight Therapeutics, Inc. (Knight) that provides Knight with exclusive rights to commercialize tenapanor in Canada. Tenapanor is…
Read More...

Nexcelom Bioscience announced that it has received a strategic investment from Ampersand Capital Partners. The funding will be primarily used to support Nexcelom's worldwide growth…
Read More...

Global pharmaceutical company Mylan N.V. announced the U.S. launch of the oncology drug Mitomycin for Injection USP, 5 mg/vial, 20 mg/vial and 40 mg/vial Single Dose Vials, a generic…
Read More...

Akcea Therapeutics United Kingdom (UK) Ltd announced that volanesorsen has been granted a positive scientific opinion through the Early Access to Medicines Scheme (EAMS) by the UK’s…
Read More...

Kalytera Therapeutics announced that it has begun development of a novel cannabinoid-based compound for the treatment of acute and chronic pain. Patents for this compound have been…
Read More...

Standardizing and personalizing insulin therapy management for hospitalized patients is a goal Piedmont Healthcare is poised to achieve through expanded use of Glytec’s eGlycemic…
Read More...

Elligo Health Research, which improves clinical trial access by engaging the 97 percent of physicians currently not offering clinical research to their patients, announced today $16…
Read More...

Bicycle Therapeutics, a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic peptide (Bicycle) product platform, announced the promotion of…
Read More...

Intezyne, a clinical-stage biopharmaceutical company developing novel anti-cancer therapies, announced that it has partnered with Exosome Diagnostics, a privately held company focused…
Read More...

Sartorius Stedim Biotech (SSB) announced the launch of the ambr 250 high throughput (ht) perfusion, a new automated parallel bioreactor system. It has been specially designed for rapid…
Read More...

X-Chem, Inc. announced the appointment of Christelle Huguet, Ph.D. as Chief Scientific Officer, along with an executive leadership appointment for Matthew Clark, Ph.D. as Senior Vice…
Read More...

Dr. Reddy’s Laboratories Ltd announced that it has launched Levocetirizine Dihydrochloride Tablets USP, 5 mg, an over-the-counter therapeutic equivalent generic version of Xyzal Allergy…
Read More...

Dalton Pharma Services has declared the signing of a drug development and manufacturing services agreement with Oryn Therapeutics, an American biotechnology firm committed to the…
Read More...

Certara announced the launch of its Quantitative Systems Pharmacology (QSP) Immuno-oncology Simulator Consortium. QSP combines computational modeling and experimental methods to…
Read More...

Proteostasis Therapeutics announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for PTI-428, the Company’s cystic fibrosis transmembrane…
Read More...

MEDISCA announced that an out-licensing agreement has been signed with California-based Torrey Hills Technologies Inc., for its innovative ointment mill cleaning tool for ProMill™. The…
Read More...

One in 10 people in America is fighting a rare disease, or a disorder that affects fewer than 200,000 Americans. Although there are more than 7,000 rare diseases that collectively…
Read More...

Bio-Techne has released MimEX™ GI, a new product line for generating 3-dimensional (3-D) gastrointestinal tissue on a 2-D surface. 3-D cell culture and organoid models of the…
Read More...

Ionis Pharmaceuticals and Akcea Therapeutics announced an exclusive, worldwide license by Ionis to Akcea for inotersen and AKCEA-TTR-LRx, formerly IONIS-TTR-LRx, in a transaction…
Read More...

Recipharm, the contract development and manufacturing organisation (CDMO), announces its new Blow-fill-seal machinery is now operational following a substantial investment last year at…
Read More...